Piramal profits up 25% on domestic growth
This article was originally published in Scrip
Executive Summary
Piramal Healthcare (previously Nicholas Piramal) has reported a 25% increase in net profits to Rs851 million ($17.6 million) for the first quarter ended June 30th, buoyed by strong growth in the domestic formulations business.